| Clinical Characteristics and Therapeutic Responses in Patients with Germ-Line AIP Mutations and Pituitary Adenomas: An International Collaborative Study AF Daly, MA Tichomirowa, P Petrossians, E Heliovaara, ML Jaffrain-Rea, ... The Journal of Clinical Endocrinology & Metabolism 95 (11), E373-E383, 2010 | 398 | 2010 |
| Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families AF Daly, JF Vanbellinghen, SK Khoo, ML Jaffrain-Rea, LA Naves, ... The Journal of Clinical Endocrinology & Metabolism 92 (5), 1891-1896, 2007 | 364 | 2007 |
| Imprinting of the Gsα gene GNAS1 in the pathogenesis of acromegaly BE Hayward, A Barlier, M Korbonits, AB Grossman, P Jacquet, A Enjalbert, ... The Journal of clinical investigation 107 (6), R31-R36, 2001 | 349 | 2001 |
| Gigantism and Acromegaly Due to Xq26 Microduplications and GPR101 Mutation G Trivellin, AF Daly, FR Faucz, B Yuan, L Rostomyan, DO Larco, ... New England Journal of Medicine 371 (25), 2363-2374, 2014 | 333 | 2014 |
| Absence of IDH mutation identifies a novel radiologic and molecular subtype of WHO grade II gliomas with dismal prognosis P Metellus, B Coulibaly, C Colin, AM de Paula, A Vasiljevic, D Taieb, ... Acta neuropathologica 120, 719-729, 2010 | 321 | 2010 |
| Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary … A Saveanu, E Lavaque, G Gunz, A Barlier, S Kim, JE Taylor, MD Culler, ... The Journal of Clinical Endocrinology & Metabolism 87 (12), 5545-5552, 2002 | 198 | 2002 |
| Clinical and genetic characterization of pituitary gigantism: an international collaborative study in 208 patients L Rostomyan, AF Daly, P Petrossians, E Nachev, AR Lila, AL Lecoq, ... Endocrine-related cancer 22 (5), 745-757, 2015 | 190 | 2015 |
| Genetic screening of combined pituitary hormone deficiency: experience in 195 patients R Reynaud, M Gueydan, A Saveanu, S Vallette-Kasic, A Enjalbert, T Brue, ... The Journal of Clinical Endocrinology & Metabolism 91 (9), 3329-3336, 2006 | 184 | 2006 |
| High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas MA Tichomirowa, A Barlier, AF Daly, ML Jaffrain-Rea, C Ronchi, ... European Journal of Endocrinology 165 (4), 509-515, 2011 | 177 | 2011 |
| Heterogeneous genetic background of the association of pheochromocytoma/paraganglioma and pituitary adenoma: results from a large patient cohort J Dénes, F Swords, E Rattenberry, K Stals, M Owens, T Cranston, ... The Journal of Clinical Endocrinology & Metabolism 100 (3), E531-E541, 2015 | 176 | 2015 |
| Expression of aryl hydrocarbon receptor (AHR) and AHR-interacting protein in pituitary adenomas: pathological and clinical implications ML Jaffrain-Rea, M Angelini, D Gargano, MA Tichomirowa, AF Daly, ... Endocrine-related cancer 16 (3), 1029-1043, 2009 | 168 | 2009 |
| Genetic analysis in young patients with sporadic pituitary macroadenomas: besides AIP don't forget MEN1 genetic analysis T Cuny, M Pertuit, M Sahnoun-Fathallah, A Daly, G Occhi, MF Odou, ... European Journal of Endocrinology 168 (4), 533-541, 2013 | 160 | 2013 |
| Mutations in the Aryl Hydrocarbon Receptor Interacting Protein Gene Are Not Highly Prevalent among Subjects with Sporadic Pituitary Adenomas A Barlier, JF Vanbellinghen, AF Daly, M Silvy, ML Jaffrain-Rea, J Trouillas, ... The Journal of Clinical Endocrinology & Metabolism 92 (5), 1952-1955, 2007 | 160 | 2007 |
| From pseudohypoparathyroidism to inactivating PTH/PTHrP signalling disorder (iPPSD), a novel classification proposed by the EuroPHP network S Thiele, G Mantovani, A Barlier, V Boldrin, P Bordogna, L De Sanctis, ... European Journal of Endocrinology 175 (6), P1-P17, 2016 | 147 | 2016 |
| PROP1 Gene Screening in Patients with Multiple Pituitary Hormone Deficiency Reveals Two Sites of Hypermutability and a High Incidence of Corticotroph Deficiency S Vallette-Kasic, A Barlier, C Teinturier, A Diaz, M Manavela, ... The Journal of Clinical Endocrinology & Metabolism 86 (9), 4529-4535, 2001 | 146 | 2001 |
| 18F-FDG avidity of pheochromocytomas and paragangliomas: a new molecular imaging signature? D Taïeb, F Sebag, A Barlier, L Tessonnier, FF Palazzo, I Morange, ... Journal of Nuclear Medicine 50 (5), 711-717, 2009 | 143 | 2009 |
| Pronostic and Therapeutic Consequences of Gsα Mutations in Somatotroph Adenomas A Barlier, G Gunz, AJ Zamora, I Morange-Ramos, D Figarella-Branger, ... The Journal of Clinical Endocrinology & Metabolism 83 (5), 1604-1610, 1998 | 143 | 1998 |
| Congenital Isolated Adrenocorticotropin Deficiency: An Underestimated Cause of Neonatal Death, Explained by TPIT Gene Mutations S Vallette-Kasic, T Brue, AM Pulichino, M Gueydan, A Barlier, M David, ... The Journal of Clinical Endocrinology & Metabolism 90 (3), 1323-1331, 2005 | 137 | 2005 |
| Quinagolide–a valuable treatment option for hyperprolactinaemia A Barlier, P Jaquet European journal of endocrinology 154 (2), 187-195, 2006 | 134 | 2006 |
| Pituitary stalk interruption syndrome in 83 patients: novel HESX1 mutation and severe hormonal prognosis in malformative forms R Reynaud, F Albarel, A Saveanu, N Kaffel, F Castinetti, P Lecomte, ... European journal of endocrinology 164 (4), 457-465, 2011 | 133 | 2011 |
